Lower Insulin-Dose Adjusted A1c (IDAA1c) Is Associated With Less Complications in Individuals With Type 1 Diabetes Treated With Hematopoetic Stem-Cell Transplantation and Conventional Therapy

Lower Insulin-Dose Adjusted A1c (IDAA1c) Is Associated With Less Complications in Individuals With Type 1 Diabetes Treated With Hematopoetic Stem-Cell Transplantation and Conventional Therapy

Objective: To evaluate the association between insulin-dose adjusted A1C (IDAA1c) and microvascular complications (MC) and hypoglycemia in a representative Brazilian population of Type 1 diabetes mellitus (T1DM) patients.Research Design and Methods: This was a cross-sectional study based on a previo...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Jaquellyne Gurgel Penaforte-Saboia, Carlos Eduardo Barra Couri, Virginia Oliveira Fernandes, Ana Paula Dias Rangel Montenegro, Lívia Aline De Araújo Batista, Lenita Zajdenverg, Carlos Antonio Negrato, Kelen Cristina Ribeiro Malmegrim, Daniela Aparecida Moraes, Juliana Bernardes Elias Dias, Maria Carolina Oliveira, Akhtar Hussain, Marilia Brito Gomes, Renan Magalhães Montenegro
Formaat: Artikel
Taal:English
Gepubliceerd in: Frontiers Media S.A. 2019-11-01
Reeks:Frontiers in Endocrinology
Onderwerpen:
type 1 diabetes (T1D)
IDAA1c
residual B-cell function
glycemic control
microvascular complications
Online toegang:https://www.frontiersin.org/article/10.3389/fendo.2019.00747/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00747/full

Gelijkaardige items